Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Azithromycin"" wg kryterium: Temat


Tytuł :
Protective effect of Rosuvastatin on Azithromycin induced cardiotoxicity in a rat model.
Autorzy :
Mansour BS; Anatomy Department, Faculty of Medicine, Suez Canal University, Egypt.
Salem NA; Anatomy Department, Faculty of Medicine, Suez Canal University, Egypt.
Kader GA; Anatomy Department, Faculty of Medicine, Suez Canal University, Egypt.
Abdel-Alrahman G; Anatomy Department, Faculty of Medicine, Suez Canal University, Egypt.
Mahmoud OM; Anatomy Department, Faculty of Medicine, Suez Canal University, Egypt. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 Mar 15; Vol. 269, pp. 119099. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Bacterial Agents/*adverse effects
Azithromycin/*adverse effects
Cardiotoxicity/*prevention & control
Rosuvastatin Calcium/*pharmacology
Animals ; Anti-Bacterial Agents/administration & dosage ; Antioxidants/administration & dosage ; Antioxidants/pharmacology ; Apoptosis/drug effects ; Azithromycin/administration & dosage ; COVID-19/drug therapy ; Cardiotoxicity/etiology ; Disease Models, Animal ; Glutathione/metabolism ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Inflammation/chemically induced ; Inflammation/prevention & control ; Male ; Malondialdehyde/metabolism ; Oxidative Stress/drug effects ; Rats ; Rats, Sprague-Dawley ; Rosuvastatin Calcium/administration & dosage
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial.
Autorzy :
Gyselinck I; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium. .
Liesenborgs L; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
Landeloos E; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
Belmans A; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Leuven, Belgium.
Verbeke G; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Leuven, Belgium.
Verhamme P; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
Vos R; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
Janssens W; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
Pokaż więcej
Corporate Authors :
DAWn-Azithro consortium
Źródło :
Trials [Trials] 2021 Feb 09; Vol. 22 (1), pp. 126. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :
Clinical Trial Protocol; Journal Article
MeSH Terms :
Standard of Care*
Antiviral Agents/*adverse effects
Azithromycin/*adverse effects
COVID-19/*drug therapy
SARS-CoV-2/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antiviral Agents/administration & dosage ; Azithromycin/administration & dosage ; Belgium/epidemiology ; COVID-19/epidemiology ; COVID-19/virology ; Female ; Humans ; Hydroxychloroquine/therapeutic use ; Length of Stay ; Male ; Middle Aged ; Multicenter Studies as Topic ; Polymerase Chain Reaction ; Proof of Concept Study ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Young Adult
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
Autorzy :
Sarayani A; Center for Drug Evaluation and Safety, Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL, USA.
Cicali B; Center for Systems Pharmacology and Pharmacometrics, Department of Pharmaceutics, University of Florida College of Pharmacy, Orlando, FL, USA.
Henriksen CH; Center for Drug Evaluation and Safety, Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL, USA.
Brown JD; Center for Drug Evaluation and Safety, Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL, USA. Electronic address: .
Pokaż więcej
Źródło :
Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2021 Feb; Vol. 17 (2), pp. 483-486. Date of Electronic Publication: 2020 Apr 19.
Typ publikacji :
Journal Article
MeSH Terms :
Antiviral Agents/*therapeutic use
Azithromycin/*therapeutic use
Chloroquine/*therapeutic use
Hydroxychloroquine/*therapeutic use
Long QT Syndrome/*chemically induced
Torsades de Pointes/*chemically induced
Antiviral Agents/adverse effects ; Azithromycin/adverse effects ; COVID-19/complications ; COVID-19/drug therapy ; Chloroquine/adverse effects ; Drug Interactions ; Drug Therapy, Combination ; Humans ; Hydroxychloroquine/adverse effects ; Long QT Syndrome/mortality ; Pharmacovigilance ; Torsades de Pointes/mortality ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Are clarithromycin, azithromycin and their analogues effective in the treatment of COVID19?
Autorzy :
Gedikli MA
Tuzun B
Aktas A
Sayin K
Ataseven H
Pokaż więcej
Źródło :
Bratislavske lekarske listy [Bratisl Lek Listy] 2021; Vol. 122 (2), pp. 101-110.
Typ publikacji :
Journal Article
MeSH Terms :
Azithromycin/*therapeutic use
COVID-19/*drug therapy
Clarithromycin/*therapeutic use
Antiviral Agents/pharmacology ; Azithromycin/pharmacology ; Clarithromycin/pharmacology ; Humans ; RNA, Viral ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19.
Autorzy :
Echarte-Morales J; Department of Cardiology, University Hospital of León, León, Spain.
Minguito-Carazo C; Department of Cardiology, University Hospital of León, León, Spain.
Del Castillo-García S; Department of Cardiology, University Hospital of León, León, Spain.
Borrego-Rodríguez J; Department of Cardiology, University Hospital of León, León, Spain.
Rodríguez-Santamarta M; Department of Cardiology, University Hospital of León, León, Spain.
Sánchez-Muñoz E; Department of Cardiology, University Hospital of León, León, Spain.
Bergel-García R; Department of Cardiology, University Hospital of León, León, Spain.
González-Maniega C; Department of Cardiology, University Hospital of León, León, Spain.
Prieto-González S; Department of Cardiology, University Hospital of León, León, Spain.
Menéndez-Suarez P; Department of Cardiology, University Hospital of León, León, Spain.
Tundidor-Sanz E; Department of Cardiology, University Hospital of León, León, Spain.
Benito-González T; Department of Cardiology, University Hospital of León, León, Spain. Electronic address: .
Fernández-Vázquez F; Department of Cardiology, University Hospital of León, León, Spain.
Pokaż więcej
Źródło :
Journal of electrocardiology [J Electrocardiol] 2021 Jan-Feb; Vol. 64, pp. 30-35. Date of Electronic Publication: 2020 Nov 28.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Azithromycin/*pharmacology
COVID-19/*physiopathology
Electrocardiography/*drug effects
Hydroxychloroquine/*pharmacology
Lopinavir/*pharmacology
Ritonavir/*pharmacology
Aged ; Anti-Infective Agents/pharmacology ; Anti-Infective Agents/therapeutic use ; Azithromycin/therapeutic use ; COVID-19/drug therapy ; Drug Therapy, Combination ; Female ; HIV Protease Inhibitors/pharmacology ; HIV Protease Inhibitors/therapeutic use ; Humans ; Hydroxychloroquine/therapeutic use ; Kaplan-Meier Estimate ; Lopinavir/therapeutic use ; Male ; Middle Aged ; Prospective Studies ; Ritonavir/therapeutic use
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection.
Autorzy :
Moschini L; Division of Cardiology, Ospedale di Cremona, Viale Concordia 1, 26100, Cremona, Italy.
Loffi M; Division of Cardiology, Ospedale di Cremona, Viale Concordia 1, 26100, Cremona, Italy.
Regazzoni V; Division of Cardiology, Ospedale di Cremona, Viale Concordia 1, 26100, Cremona, Italy.
Di Tano G; Division of Cardiology, Ospedale di Cremona, Viale Concordia 1, 26100, Cremona, Italy.
Gherbesi E; Università degli Studi di Milano, Via Festa del Perdono 7, 20122, Milano, Italy.
Danzi GB; Division of Cardiology, Ospedale di Cremona, Viale Concordia 1, 26100, Cremona, Italy. .
Pokaż więcej
Źródło :
Heart and vessels [Heart Vessels] 2021 Jan; Vol. 36 (1), pp. 115-120. Date of Electronic Publication: 2020 Jul 16.
Typ publikacji :
Journal Article
MeSH Terms :
Azithromycin/*adverse effects
COVID-19/*drug therapy
Darunavir/*adverse effects
Electrocardiography/*drug effects
Hydroxychloroquine/*therapeutic use
Long QT Syndrome/*chemically induced
Ritonavir/*adverse effects
Aged ; Anti-Bacterial Agents/adverse effects ; Anti-Bacterial Agents/therapeutic use ; Azithromycin/therapeutic use ; COVID-19/epidemiology ; Darunavir/therapeutic use ; Enzyme Inhibitors/therapeutic use ; Female ; Humans ; Long QT Syndrome/physiopathology ; Male ; Middle Aged ; Ritonavir/therapeutic use ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Azithromycin in patients with COVID-19: Friend or foe?
Autorzy :
Kow CS; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia. Electronic address: .
Hasan SS; Department of Pharmacy, University of Huddersfield, Huddersfield, UK; School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia.
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Jan; Vol. 27 (1), pp. 136-137. Date of Electronic Publication: 2020 Sep 29.
Typ publikacji :
Letter; Comment
MeSH Terms :
Azithromycin*
COVID-19*
Humans ; Hydroxychloroquine ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic.
Autorzy :
Vouri SM; Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL, USA; Center for Drug Evaluation and Safety, University of Florida, Gainesville, FL, USA; University of Florida Health Physicians, Gainesville, FL, USA.
Thai TN; Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL, USA.
Winterstein AG; Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL, USA; Center for Drug Evaluation and Safety, University of Florida, Gainesville, FL, USA. Electronic address: .
Pokaż więcej
Źródło :
Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2021 Jan; Vol. 17 (1), pp. 2012-2017. Date of Electronic Publication: 2020 Apr 30.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Azithromycin/*administration & dosage
COVID-19/*epidemiology
Chloroquine/*administration & dosage
Heart Diseases/*epidemiology
Hydroxychloroquine/*administration & dosage
Pharmacoepidemiology/*methods
Adolescent ; Adult ; Aged ; Azithromycin/adverse effects ; COVID-19/drug therapy ; Chloroquine/adverse effects ; Cohort Studies ; Drug Therapy, Combination/adverse effects ; Female ; Heart Diseases/chemically induced ; Humans ; Hydroxychloroquine/adverse effects ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al.
Autorzy :
Lacout A; Centre de Diagnostic, ELSAN, Centre Médico-Chirurgical, 83 avenue Charles de Gaulle, 15000 Aurillac, France. Electronic address: .
Marcy PY; Radiodiagnostics and Interventional Radiology Department, ELSAN, Polyclinique Les Fleurs, Quartier Quiez, 83190 Ollioules, France.
Perronne C; Infectious Diseases Unit, University Hospital Raymond Poincaré, APHP Versailles Saint Quentin University Garches, France.
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Jan; Vol. 27 (1), pp. 134-135. Date of Electronic Publication: 2020 Sep 25.
Typ publikacji :
Letter; Comment
MeSH Terms :
Azithromycin*/therapeutic use
COVID-19*
Drug Therapy, Combination ; Hospitalization ; Humans ; Hydroxychloroquine/therapeutic use ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al.
Autorzy :
Million M; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.
Roussel Y; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.
Lagier JC; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.
Raoult D; IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France. Electronic address: .
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Jan; Vol. 27 (1), pp. 132-133. Date of Electronic Publication: 2020 Sep 24.
Typ publikacji :
Letter; Comment
MeSH Terms :
Azithromycin*/therapeutic use
COVID-19*
Drug Therapy, Combination ; Hospitalization ; Humans ; Hydroxychloroquine/therapeutic use ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.
Autorzy :
García-Fernández A; Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain. Electronic address: .
Ramos-Ruiz P; Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Ibáñez-Criado A; Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Moreno-Pérez Ó; Departamento de Endocrinología y Nutrición, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain; Departamento de Medicina Clínica, Universidad Miguel Hernández, Elche, Alicante, Spain.
Cambra-Poveda C; Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Martínez-Martínez JG; Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Pokaż więcej
Corporate Authors :
Research Investigation COVID-19 Alicante
Źródło :
Revista espanola de cardiologia (English ed.) [Rev Esp Cardiol (Engl Ed)] 2021 Jan; Vol. 74 (1), pp. 108-111. Date of Electronic Publication: 2020 Oct 01.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Azithromycin/*adverse effects
COVID-19/*drug therapy
Electrocardiography/*methods
Hydroxychloroquine/*adverse effects
Long QT Syndrome/*diagnosis
Aged ; Anti-Bacterial Agents/adverse effects ; Anti-Bacterial Agents/therapeutic use ; Antimalarials/adverse effects ; Antimalarials/therapeutic use ; Azithromycin/therapeutic use ; COVID-19/epidemiology ; Drug Therapy, Combination ; Electrocardiography/drug effects ; Female ; Humans ; Hydroxychloroquine/therapeutic use ; Long QT Syndrome/chemically induced ; Long QT Syndrome/physiopathology ; SARS-CoV-2
Raport
Tytuł :
QT interval evaluation associated with the use of hydroxychloroquine with combined use of azithromycin among hospitalised children positive for coronavirus disease 2019.
Autorzy :
Tuncer T; Department of Pediatrics, Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey.
Karaci M; Department of Pediatrics, Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey.
Boga A; Department of Pediatrics, Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey.
Durmaz H; Department of Pediatrics, Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey.
Guven S; Department of Pediatrics, Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey.
Pokaż więcej
Źródło :
Cardiology in the young [Cardiol Young] 2020 Oct; Vol. 30 (10), pp. 1482-1485. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji :
Journal Article
MeSH Terms :
Azithromycin*/administration & dosage
Azithromycin*/adverse effects
Hydroxychloroquine*/administration & dosage
Hydroxychloroquine*/adverse effects
Long QT Syndrome*/chemically induced
Long QT Syndrome*/diagnosis
Long QT Syndrome*/prevention & control
Coronavirus Infections/*drug therapy
Electrocardiography/*methods
Pneumonia, Viral/*drug therapy
Adolescent ; Anti-Infective Agents/administration & dosage ; Anti-Infective Agents/adverse effects ; COVID-19 ; Child ; Coronavirus Infections/diagnosis ; Coronavirus Infections/epidemiology ; Female ; Hospitalization/statistics & numerical data ; Humans ; Male ; Outcome and Process Assessment, Health Care ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; Retrospective Studies ; Turkey/epidemiology
Czasopismo naukowe
Tytuł :
Azithromycin: The First Broad-spectrum Therapeutic.
Autorzy :
Firth A; New Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK.
Prathapan P; New Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK. Electronic address: .
Pokaż więcej
Źródło :
European journal of medicinal chemistry [Eur J Med Chem] 2020 Dec 01; Vol. 207, pp. 112739. Date of Electronic Publication: 2020 Aug 19.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anti-Inflammatory Agents/*therapeutic use
Antiviral Agents/*therapeutic use
Azithromycin/*therapeutic use
Coronavirus Infections/*drug therapy
Pneumonia, Viral/*drug therapy
Animals ; Anti-Inflammatory Agents/adverse effects ; Antiviral Agents/adverse effects ; Azithromycin/adverse effects ; Betacoronavirus ; COVID-19 ; Cell Line, Tumor ; Humans ; Immunologic Factors/adverse effects ; Immunologic Factors/therapeutic use ; Macrophages/metabolism ; Pandemics ; SARS-CoV-2
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Effect of Once-Weekly Azithromycin vs Placebo in Children With HIV-Associated Chronic Lung Disease: The BREATHE Randomized Clinical Trial.
Autorzy :
Ferrand RA; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Biomedical Research and Training Institute, Harare, Zimbabwe.
McHugh G; Biomedical Research and Training Institute, Harare, Zimbabwe.
Rehman AM; MRC International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Mujuru H; Department of Paediatrics, University of Zimbabwe, Harare, Zimbabwe.
Simms V; Biomedical Research and Training Institute, Harare, Zimbabwe.; MRC International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Majonga ED; Biomedical Research and Training Institute, Harare, Zimbabwe.
Nicol MP; Division of Clinical Microbiology, University of Cape Town, Cape Town, South Africa.; School of Biomedical Sciences, University of Western Australia, Perth, Australia.
Flaegstad T; Faculty of Health Sciences, UiT, The Arctic University of Norway, Tromsø, Norway.; Department of Paediatrics, University Hospital of North Norway, Tromsø, Norway.
Gutteberg TJ; Faculty of Health Sciences, UiT, The Arctic University of Norway, Tromsø, Norway.; Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.
Gonzalez-Martinez C; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; Department of Paediatrics and Child Health, University of Malawi College of Medicine, Blantyre, Malawi.
Corbett EL; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Rowland-Jones SL; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Kranzer K; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Biomedical Research and Training Institute, Harare, Zimbabwe.
Weiss HA; MRC International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Odland JO; Faculty of Health Sciences, UiT, The Arctic University of Norway, Tromsø, Norway.; School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Pokaż więcej
Corporate Authors :
BREATHE Trial Group
Źródło :
JAMA network open [JAMA Netw Open] 2020 Dec 01; Vol. 3 (12), pp. e2028484. Date of Electronic Publication: 2020 Dec 01.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Azithromycin*/administration & dosage
Azithromycin*/adverse effects
Pulmonary Disease, Chronic Obstructive*/drug therapy
Pulmonary Disease, Chronic Obstructive*/etiology
Pulmonary Disease, Chronic Obstructive*/physiopathology
HIV Infections/*complications
Respiratory Tract Infections/*drug therapy
Adolescent ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/adverse effects ; Double-Blind Method ; Drug Dosage Calculations ; Female ; Hospitalization/statistics & numerical data ; Humans ; Male ; Respiratory Tract Infections/immunology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study.
Autorzy :
Derwand R; Alexion Pharma Germany GmbH, 80687, Munich, Germany.
Scholz M; Heinrich-Heine-University, Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany. Electronic address: .
Zelenko V; Medical Group Practice, Monroe, NY, 10950, USA.
Pokaż więcej
Źródło :
International journal of antimicrobial agents [Int J Antimicrob Agents] 2020 Dec; Vol. 56 (6), pp. 106214. Date of Electronic Publication: 2020 Oct 26.
Typ publikacji :
Journal Article
MeSH Terms :
SARS-CoV-2*
Azithromycin/*administration & dosage
COVID-19/*drug therapy
Hydroxychloroquine/*administration & dosage
Zinc/*administration & dosage
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Azithromycin/adverse effects ; Drug Therapy, Combination ; Female ; Humans ; Hydroxychloroquine/adverse effects ; Male ; Middle Aged ; Outpatients ; Retrospective Studies ; Young Adult ; Zinc/adverse effects
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Reduction of Coronavirus Burden With Mass Azithromycin Distribution.
Autorzy :
Doan T; Francis I. Proctor Foundation, San Francisco, California, USA.; University of California, San Francisco, San Francisco, California, USA.
Hinterwirth A; Francis I. Proctor Foundation, San Francisco, California, USA.; University of California, San Francisco, San Francisco, California, USA.
Arzika AM; Carter Center, Niamey, Niger.
Worden L; Francis I. Proctor Foundation, San Francisco, California, USA.
Chen C; Francis I. Proctor Foundation, San Francisco, California, USA.
Zhong L; Francis I. Proctor Foundation, San Francisco, California, USA.
Oldenburg CE; Francis I. Proctor Foundation, San Francisco, California, USA.; University of California, San Francisco, San Francisco, California, USA.
Keenan JD; Francis I. Proctor Foundation, San Francisco, California, USA.; University of California, San Francisco, San Francisco, California, USA.
Lietman TM; Francis I. Proctor Foundation, San Francisco, California, USA.; University of California, San Francisco, San Francisco, California, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Nov 19; Vol. 71 (16), pp. 2282-2284.
Typ publikacji :
Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Mass Drug Administration*
Antiviral Agents/*therapeutic use
Azithromycin/*therapeutic use
Coronavirus Infections/*drug therapy
Nasopharynx/*virology
Viral Load/*drug effects
Administration, Oral ; Antiviral Agents/administration & dosage ; Azithromycin/administration & dosage ; Child, Preschool ; Coronavirus/drug effects ; Coronavirus Infections/mortality ; Humans ; Infant ; Infant, Newborn ; Nigeria/epidemiology
Czasopismo naukowe
Tytuł :
Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era.
Autorzy :
Saleh M; Department of Cardiology (M.S., J.G., D.C., S.E.M., L.M.E.), The Feinstein Institutes for Medical Research, Northwell Health, NY.
Gabriels J; Department of Cardiology (M.S., J.G., D.C., S.E.M., L.M.E.), The Feinstein Institutes for Medical Research, Northwell Health, NY.
Chang D; Department of Cardiology (M.S., J.G., D.C., S.E.M., L.M.E.), The Feinstein Institutes for Medical Research, Northwell Health, NY.
Fishbein J; Biostatistics Unit (J.F.), The Feinstein Institutes for Medical Research, Northwell Health, NY.
Qiu M; Institute of Health Innovations and Outcomes Research & Center for Research Informatics & Innovation (M.Q.), The Feinstein Institutes for Medical Research, Northwell Health, NY.
Mountantonakis SE; Department of Cardiology (M.S., J.G., D.C., S.E.M., L.M.E.), The Feinstein Institutes for Medical Research, Northwell Health, NY.
Epstein LM; Department of Cardiology (M.S., J.G., D.C., S.E.M., L.M.E.), The Feinstein Institutes for Medical Research, Northwell Health, NY.
Pokaż więcej
Corporate Authors :
Northwell COVID-19 Research Consortium
Źródło :
Circulation. Arrhythmia and electrophysiology [Circ Arrhythm Electrophysiol] 2020 Nov; Vol. 13 (11), pp. e008937. Date of Electronic Publication: 2020 Oct 01.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Delivery of Health Care*
Antiviral Agents/*adverse effects
Azithromycin/*adverse effects
COVID-19/*drug therapy
Heart Conduction System/*drug effects
Hydroxychloroquine/*adverse effects
Torsades de Pointes/*chemically induced
Action Potentials/drug effects ; Adolescent ; Adult ; Aged ; Antiviral Agents/administration & dosage ; Azithromycin/administration & dosage ; COVID-19/diagnosis ; Cardiotoxicity ; Female ; Heart Conduction System/physiopathology ; Heart Rate/drug effects ; Hospitalization ; Humans ; Hydroxychloroquine/administration & dosage ; Male ; Middle Aged ; New York ; Patient Safety ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Torsades de Pointes/diagnosis ; Torsades de Pointes/physiopathology ; Treatment Outcome ; Young Adult
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval.
Autorzy :
Samuel S; Section of Pediatric Cardiology and; Department of Pediatrics, Cohen Children's Medical Center, Northwell Health System, Donald and Barbara Zucker School of Medicine at Hofstra University, New Hyde Park, New York. Electronic address: .
Friedman RA; Section of Pediatric Cardiology and; Department of Pediatrics, Cohen Children's Medical Center, Northwell Health System, Donald and Barbara Zucker School of Medicine at Hofstra University, New Hyde Park, New York.
Sharma C; Section of Pediatric Cardiology and; Department of Pediatrics, Cohen Children's Medical Center, Northwell Health System, Donald and Barbara Zucker School of Medicine at Hofstra University, New Hyde Park, New York.
Ganigara M; Section of Pediatric Cardiology and; Department of Pediatrics, Cohen Children's Medical Center, Northwell Health System, Donald and Barbara Zucker School of Medicine at Hofstra University, New Hyde Park, New York.
Mitchell E; Section of Pediatric Cardiology and; Department of Pediatrics, Cohen Children's Medical Center, Northwell Health System, Donald and Barbara Zucker School of Medicine at Hofstra University, New Hyde Park, New York.
Schleien C; Department of Pediatrics, Cohen Children's Medical Center, Northwell Health System, Donald and Barbara Zucker School of Medicine at Hofstra University, New Hyde Park, New York.
Blaufox AD; Section of Pediatric Cardiology and; Department of Pediatrics, Cohen Children's Medical Center, Northwell Health System, Donald and Barbara Zucker School of Medicine at Hofstra University, New Hyde Park, New York.
Pokaż więcej
Źródło :
Heart rhythm [Heart Rhythm] 2020 Nov; Vol. 17 (11), pp. 1960-1966. Date of Electronic Publication: 2020 Jul 01.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Arrhythmias, Cardiac*/diagnosis
Arrhythmias, Cardiac*/epidemiology
Azithromycin*/administration & dosage
Azithromycin*/adverse effects
Coronavirus Infections*/diagnosis
Coronavirus Infections*/drug therapy
Coronavirus Infections*/epidemiology
Coronavirus Infections*/physiopathology
Electrocardiography*/methods
Electrocardiography*/statistics & numerical data
Hydroxychloroquine*/administration & dosage
Hydroxychloroquine*/adverse effects
Long QT Syndrome*/chemically induced
Long QT Syndrome*/diagnosis
Pandemics*
Pneumonia, Viral*/diagnosis
Pneumonia, Viral*/drug therapy
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/physiopathology
Anti-Infective Agents/administration & dosage ; Anti-Infective Agents/adverse effects ; Betacoronavirus/isolation & purification ; COVID-19 ; COVID-19 Testing ; Child ; Clinical Laboratory Techniques/methods ; Female ; Humans ; Incidence ; Male ; New York City/epidemiology ; Outcome and Process Assessment, Health Care ; Retrospective Studies ; Risk Factors ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Low hospitalization rate without severe arrhythmias: a prospective survey on 350 patients early home treated with hydroxychloroquine during COVID-19 pandemic.
Autorzy :
Capucci A; Specialization School of Cardiology, Università Politecnica delle Marche, Ancona.
Santarelli A; Cardiovascular Department.
Bartolomei M; Primary Care Department.
Paolizzi C; Primary Care Department.
Biagetti C; Infectious Disease Unit of Rimini, AUSL Romagna, Rimini, Italy.
Dappozzo A; Primary Care Department.
Piovaccari G; Cardiovascular Department.
Pokaż więcej
Źródło :
Journal of cardiovascular medicine (Hagerstown, Md.) [J Cardiovasc Med (Hagerstown)] 2020 Nov; Vol. 21 (11), pp. 922-923.
Typ publikacji :
Letter
MeSH Terms :
Arrhythmias, Cardiac*/diagnosis
Arrhythmias, Cardiac*/etiology
Azithromycin*/administration & dosage
Azithromycin*/adverse effects
Coronavirus Infections*/diagnosis
Coronavirus Infections*/drug therapy
Coronavirus Infections*/epidemiology
Coronavirus Infections*/physiopathology
Hydroxychloroquine*/administration & dosage
Hydroxychloroquine*/adverse effects
Pandemics*
Pneumonia, Viral*/diagnosis
Pneumonia, Viral*/drug therapy
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/physiopathology
Hospitalization/*statistics & numerical data
Anti-Infective Agents/administration & dosage ; Anti-Infective Agents/adverse effects ; Betacoronavirus ; COVID-19 ; COVID-19 Testing ; Clinical Laboratory Techniques/methods ; Drug-Related Side Effects and Adverse Reactions/diagnosis ; Humans ; Italy/epidemiology ; Outcome Assessment, Health Care ; SARS-CoV-2 ; Time-to-Treatment
SCR Protocol :
COVID-19 drug treatment
Opinia redakcyjna
Tytuł :
Randomised trial of azithromycin to eradicate Ureaplasma in preterm infants.
Autorzy :
Viscardi RM; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA .
Terrin ML; Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Magder LS; Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Davis NL; Department of Pediatrics, University of Maryland Baltimore, Baltimore, Maryland, USA.
Dulkerian SJ; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Waites KB; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Ambalavanan N; Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Kaufman DA; Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Donohue P; Department of Pediatrics, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Tuttle DJ; Department of Pediatrics, Christiana Care Health System, Newark, Delaware, USA.
Weitkamp JH; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Hassan HE; University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Eddington ND; University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Pokaż więcej
Źródło :
Archives of disease in childhood. Fetal and neonatal edition [Arch Dis Child Fetal Neonatal Ed] 2020 Nov; Vol. 105 (6), pp. 615-622. Date of Electronic Publication: 2020 Mar 13.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
MeSH Terms :
Anti-Bacterial Agents/*therapeutic use
Azithromycin/*therapeutic use
Infant, Premature, Diseases/*drug therapy
Respiratory Tract Infections/*drug therapy
Ureaplasma Infections/*drug therapy
Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/pharmacokinetics ; Azithromycin/administration & dosage ; Azithromycin/pharmacokinetics ; Bronchopulmonary Dysplasia/etiology ; Double-Blind Method ; Drug Administration Schedule ; Female ; Gestational Age ; Humans ; Infant, Extremely Premature ; Infant, Newborn ; Intensive Care Units, Neonatal ; Intention to Treat Analysis ; Male ; Prospective Studies ; Respiratory Tract Infections/complications ; Risk Factors ; Ureaplasma Infections/complications
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies